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1. Introduction  
Iodine deficiency is a worldwide Public Health problem, mainly in pregnant women and 
infants, which causes permanent and irreversible sequels in the Central Nervous System 
(CNS) of the progeny when daily iodine intake does not reach optimal levels. 
Pharmacological iodine supplements have been recommended during pregnancy and 
lactation periods in regions with low iodine intake diet.  
In recent years, maternal hypothyroxinemia has been recognized as the biochemical 
condition responsible for the alterations in the processes of neural development in the 
embryo and fetus associated to iodine deficiency. 
Research Methods: The objective of this study was to review the available scientific evidence 
on the crucial role of iodine in early stages of neural development, to understand the 
international scheduling recommendations about an adequate iodine intake in vulnerable 
populations groups. 
Iodine is a micronutrient essential for the synthesis of thyroid hormones1. The thyroid gland 
takes iodine from the diet, stores it and subsequently incorporates it into other molecules, to 
produce two types of thyroid hormones as a final product: triiodothyronine (T3) and 
thyroxine (T4) containing three and four iodine atoms respectively. Both circulate in blood 
bound to proteins and act on specific receptors. The free T3 is metabolically more active, but 
the T4 is, as we shall see, indispensable at specific developmental stages.  
The thyroid hormones are involved in many metabolic and developmental processes, and 
they exert a broad range of actions on every tissue of the body: body temperature 
regulation, somatic growth. Further, it is essential for the proper development and function 
of the Central Nervous System.2  
Since the first epidemiological studies conducted by Pharoah3 and Thilly4 in the 70's, the 
association between iodine deficiency in pregnant women and fetal neurological damage 
has been extensively reviewed and proven in scientific literature. In fact, the need to provide 
iodine supplementation to pregnant women in iodine-deficient regions is considered as 
proven by scientific evidence.5 
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Many of these studies are focused on regions where severe iodine deficiency is endemic and 
coexisting with mixedematous cretinism.6 The understanding of the neurological effects of 
hypothyroidism on infants was partially obtained from mothers with clinically overt 
hypothyroidism.7.8 All these factors have contributed to a general awareness that iodine 
deficiency is a problem restricted to specific geographic areas and to well-defined at-risk 
populations (hypothyroidism, goiter and malnutrition)9 
For a long time, there has been a prevailing belief that the main factor responsible for 
alterations in fetal neurological development was maternal hypothyroidism (defined as 
elevated serum TSH levels) in the early stages of pregnancy.8,10 Thus, when a pregnant 
woman was found to have normal thyroid function, neurodevelopmental alterations in the 
fetus were systematically discarded. 11 
Along history, some contradictions have arisen from mixing different concepts as 
endemic cretinism, congenital hypothyroidism, iodine deficiency, etc12. Fortunately, such 
contradictions have been clarified by the advances in our understanding of thyroid 
physiology during pregnancy13,14 , the transfer of maternal thyroid hormones to the 
fetus15,16 and the increasingly complete characterization of thyroid hormone receptors in 
placental and embryo tissues.17 Nevertheless, only the most recent studies have given 
satisfactory explanation of the possible role of thyroid hormones (maternal and fetal) 
during critical stages of fetal neurological development.18 Basing on these recent works, 
the relevance of an adequate balance of iodine during the early stages of life is 
considered proven. 
2. Iodine deficiency and pregnancy 
Pregnancy is accompanied by dramatic changes in the thyroid function, which are the result 
of a complex combination of factors specific to pregnancy that altogether stimulate the 
maternal thyroid machinery.14 
During the first half of gestation the maternal thyroid undergoes some changes:  
 Progressive increase of thyroglobulin, which reduces free fraction of thyroxine.  
 The human chorionic gonadotropin has TSH-like effect and acts by directly stimulating 
the maternal thyroid.  
 Meanwhile, the fetal thyroid is kept inactive and will not be functioning until 20 weeks 
of gestation.  
 The only source of thyroid hormones in the fetus throughout the first half of pregnancy 
is thyroxine of maternal origin.  
In healthy pregnant women with adequate iodine levels, pregnancy mainly involves a 
higher demand of thyroid hormones. The thyroid gland regulates the release of hormones to 
achieve a new balance, and maintains this balance until the end of the gestation process19. In 
general, the higher hormone need can only be met by a proportional increase in hormone 
release, which directly depends on the intake of iodine through the diet. At present, we 
know that iodine nutritional needs increase in all pregnant women due both to the higher 
hormone need and to the higher glomerular filtration rate20. This adaptation is achieved 
without difficulty by the thyroid machinery21. 
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Conversely, when the thyroid gland fails –due, for example, to iodine deficiency–, such 
changes in thyroid parameters may not be adequately compensated and adaptation 
mechanisms fail13, 21   
 Obviously, the more severe iodine deficiency, the more serious fetal and maternal 
consequences are. However, it has been shown that such alterations can be found when 
pregnancy occurs in healthy women residing in moderately iodine-deficient areas22. 
3. Thyroid hormones and fetal brain development 
3.1 Background 
In 1888, the Clinical Society of London prepared a report which emphasized the key role of 
the thyroid gland for normal brain development23. The members of this committee reached 
this conclusion after observing that patients with both endemic and sporadic cretinism 
showed clear evidence of mental retardation.24 
Initially, endemic cretinism was thought to be a congenital disease25, 26. However, the 
prenatal origin of this syndrome was confirmed when a clinical trial with iodized oil 
showed that it could be successfully prevented exclusively when iodine was supplied to the 
mother before conception.3 
The classic works by Pharoah et al.3,27 in Papua New Guinea in the 70's, and later by Thilly 
et al4 in Ubangi (Zaire) and Malawi, provided a thorough description of the clinical 
symptoms of endemic cretinism (in its myxedema and neurological forms), which were 
characteristic of regions with severe endemic goiter. 
These early studies supported the idea that severe iodine deficiency in the mother produces 
irreversible neurological damage in the fetus during critical development stages12. Cases of 
intrauterine deaths, miscarriages, death in childhood and the birth of cretins to women with 
biochemical evidence of iodine deficiency (very low free T4 levels) without clinical signs of 
hypothyroidism were described.28, 29 
In 1976, Pharoah et al27 pointed out that iodine deficiency was different from untreated 
myxedema and from congenital hypothyroidism, which are usually associated with 
menstrual disorders, infertility or repeated miscarriage.  
Later, studies on iodine deficiency and its effects at the reproductive age and on progeny 
almost fell into oblivion in the scientific scene. It was believed that iodine deficiency had an 
impact only in certain geographic areas with severe endemic goiter, and that such dramatic 
consequences had been eradicated both in Europe and in the United States.30 
Thus, a misconception of the pathophysiology of neurological deficit caused by iodine 
deficiency was established. The placenta was thought to prevent the transfer of thyroid 
hormones.31 According to this theory, the fetal brain would develop in the absence of 
maternal transfer of these hormones32 and, therefore, neurological damage could be 
prevented by hormone supplementation therapy at birth.13 
In the following years in Europe, further clinical experience emphasized the significance of 
getting the diagnosis of congenital hypothyroidism, and initiating appropriate 
supplementation therapy as soon as possible after birth. The development of increasingly 
more precise33, 34 screening tests of thyroid function allowed to identify congenital 
hypothyroidism at birth and begin treatment without delay35. 
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However, clinical reports in regions with severe iodine deficiency suggested a different 
reality: there was a clear correlation between maternal hypothyroxinemia levels and the 
severity of neurological damage in the progeny. The lower the maternal FT4, the more 
serious the effects on the fetus, causing irreversible neurological and mental abnormalities at 
birth that could only be prevented by treating maternal hypothyroxinemia throughout the 
first half of gestation.36 Subsequent interventions could not prevent all disorders. 
But it was not until 1999 –when Haddow et al.37 published their classic article in the New 
England Journal of Medicine–  that iodine deficiency in pregnant women in developed 
countries was seen again as a problem also affecting populations that were so far thought to 
be safe from this endemic disease. Haddow et al.37 found that infants of women with 
undiagnosed hypothyroidism (TSH above the 98th percentile) during pregnancy had lower 
scores on tests related to intelligence, attention, language, reading skills, school and visual-
motor performance, and that such differences with the other infants were statistically 
significant in the 15 tests performed. 
That same year, Pop et al 38 published an article proving that fetal neural development is not 
only affected when the mother has subclinical hypothyroidism, but it is just enough that  
 
Fig. 1. Fetal and neonatal effects of iodine deficiency during pregnancy. The main advance is 
that maternal hormone transfer to the fetus during pregnancy has been definitely accepted, 
as well as the existence of damage in the progeny in absence of maternal hypothyroidism. 
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there is a previous stage of "maternal hypothyroxinemia" in the early stages of pregnancy. In 
their article, the authors showed that infants of mothers with T4 levels below the 10th 
percentile at the 12th week of gestation had significantly lower scores on the Bayley 
Psychomotor Development Scale at 10 months of age, compared with infants of mothers 
with higher free T4 levels. 
In 2000, Morreale de Escobar et al.36 presented epidemiological and experimental evidence 
strongly suggesting that first-trimester hypothyroxinemia (a low for gestational age 
circulating maternal free T4, whether or not TSH is increased) produces an increased risk for 
poor neuropsychological development of the fetus. The damage would be caused by 
decreased availability of maternal T4 to the developing brain. 
Further, poor brain development occurs both in regions with severe iodine deficiency, and 
in regions with slight or moderate deficiency.22, 28 
The identification of hypothyroxinemia  as a factor which causes neurological damage in 
progeny –regardless whether or not the mother has hypothyroidism– is a landmark for the 
study of iodine deficiency in Europe.32,36 
Figure 1 shows the differences between the classic and current understanding of the 
physiopathology of iodine deficiency.  
4. Thyroid hormones and fetal neurological development 
In humans, cerebral cortical development occurs between the 6th and the 24th week of 
gestation. The cortical plate begins to form around day 54 (8 weeks of gestation). Cortical 
neuronal migration mostly occurs between the week 8th and 24th (before the end of the 
second trimester), and generally before the onset of fetal thyroid hormone secretion occurs 
in the middle of gestation39. 
From a didactical perspective, fetal neurological development takes place in three stages 
relying on the thyroid hormone40 (Figure 2): 
1. The first stage takes place before the fetus starts producing thyroid hormones, and ends 
between the week 16th and 20th of gestation. During this period, thyroid hormone 
exposure comes only from maternally synthesized hormones, which influence neuronal 
proliferation and migration of neurons into the neocortex and hippocampus. 
2. The second stage occurs during the remainder of pregnancy after the onset of the fetal 
thyroid function, when the developing brain derives its supply of thyroid hormones 
from both the fetus and the mother. At this moment, thyroid hormones will trigger 
neurogenesis, neuronal migration, axonal outgrowth, dendritic branching and 
synaptogenesis, and the onset of glial cell differentiation and migration, and 
myelination. 
3. The third stage takes place during the neonatal and post-natal period when thyroid 
hormone supplies to the brain are entirely derived from the child and critical for 
continuing maturation. At this stage, thyroid hormones affect granule cell migration in 
the hippocampus and cerebellum, including the migration of cerebellar Purkinje cells. 
Gliogenesis and myelination continue during this stage. 
Thyroid hormone receptors (TR alpha and beta) bind T3 with very high affinity, and act as 
ligand-induced transcription factors modulating the expression of different T3-dependent 
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target genes18. Thus, although circulating levels of T4L are 4-fold higher than those of T3L, 
the thyroid hormone receptor has at least 15-fold more affinity for T340, which indicates 
that T4 is a prohormone that must be converted into T3 before the onset of thyroid 
hormone function. 
 
Fig. 2. Relationship between thyroid hormone action and brain development. In the first 
trimester of gestation, early neuronal proliferation and migration is dependent on maternal 
thyroxine (T4). In fetal tissues, deiodinase (ID-III, D3) enzyme expression falls and marks 
the onset of the fetal thyroid development. (D2: deiodinase ID-II). TRs: thyroid hormone 
receptors. From Williams GR. Neurodevelopmental and Neurophysiological Actions of thyroid 
hormones. J Neuroendocrinol 2008; 20: 784-794.  
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TR alpha and beta receptors express in most tissues, but their distribution varies from one 
tissue to another, which constitutes a control mechanism of T3 action that is specific in time 
and space.41,42 
Towards the end of the first trimester, development of the hypothalamic-pituitary axis has 
occurred and causes an increase in TSH secretion that marks the onset of fetal thyroid 
hormone production. Then starts the activating deiodinase enzyme ID-II expression and 
increases the occupation of thyroid hormone receptors by T3. 
Continuing development of the brain in the second and third trimesters relies increasingly 
on the T4 produced by both the fetus and mother. Continued post-natal development is 
entirely dependent on neonatal thyroid hormone secretion.  
Thyroid hormones intervene directly or indirectly in most of the neurodevelopmental 
processes of the embryo and the fetus. This would explain that thyroid deficiency in early 
pregnancy causes irreversible effects43,44.  
Thyroid hormone receptors have been proven to express profusely both in neurons and in 
glial cells (astrocytes and oligodendrocytes)45,46. 
At neuronal level, thyroid hormones would act as “cofactors”, favoring the expression of 
certain patterns of genes involved in axonal and dendrite outgrowth, and in the formation 
of synapses, myelination, cell migrations, and proliferation of specific cell populations39. 
For a proper neuronal function (synaptic transmission, laminar cytoarchitecture of the 
cerebral cortex) appropriate interaction with glial cells is required47. In this sense, thyroid 
hormones favor proliferation of oligodendrocyte precursor cells and their differentiation 
into mature oligodendrocytes (which make the myeline sheath)46. 
At the same time, thyroid hormones are involved in the maturation of radial glial cells, 
which are directly involved in neuronal migration into the different layers of the cerebral 
cortex.48 Finally, thyroid hormones are directly involved in the development and maturation 
of glial cells in specific brain areas, as the hippocampus or the cerebellum.44 
Thorough this sequence of events, it should be considered: 
- That fetal neurodevelopment follows a very precise and limited sequence of events47. 
The response period of the cell is what is called competence. The same cell will not 
respond before or after this period. 
- That the maturation sequence is not formed by a succession of independent events, but 
rather by cascading events where each anomaly.49,50 
5. Thyroid hormone transfer and maternal hypothyroxinemia  
In humans, maternal thyroid hormones are transferred to the fetus and the embryo during 
pregnancy. In fact, during the first half of gestation, the mother is the sole source of thyroid 
hormones51,52. 
Under normal conditions, embryonic tissues have a set of security mechanisms protecting 
their development. Some of these mechanisms are physical barriers (placenta and 
extraembryonic membranes) that avoid free transfer of maternal thyroid hormones into the 
fetus, and expose it to the same plasma fluctuations that occur in maternal blood serum53,54. 
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Another security mechanism is the presence of deiodinase enzymes in fetal cerebral 
tissues55,56. Deiodinase enzymes take maternal free thyroxine (T4L) and subsequently 
convert it into T3, but do not allow direct transfer of maternal T357. FNAs were made to 
obtain samples of fetal serum, and T4 concentrations in fetal serum were found to rely 
directly on maternal thyroxinemia58. 
In case of nutritional iodine deficiency, the organism activates self-regulating mechanisms 
where T3 is synthesized prevailingly over T4, as a way to save iodine15 (Figure 3). This leads 
to a situation of maternal hypothyroxinemia, which is the fall of T4L levels in plasma, but 
presenting normal circulating T3L and TSH levels36,57. 
Maternal hypothyroxinemia is defined as: 
- A “biochemical” status (low T4L levels with normal TSH values). 
- It appears in healthy pregnant women (without any clinical sign or underlying thyroid 
pathology). 
- It reflects a deficient nutritional status where the daily dietary intake of iodine is not 
adequate to meet iodine needs during pregnancy. 
- It indicates maternal inability to guarantee adequate T4 transfer to the embryo, which is 
required for proper neurological development36,38. 
At present there is solid evidence that maternal hypothyroxinemia (low T4L) during the first 
half of gestation is the main cause of neurological alterations in the embryo and the fetus57,59. 
Such alterations are permanent and irreversible. 
All levels of iodine deficiency (low, moderate or severe) affect the maternal and neonatal 
thyroid function, and infant’s mental development22. 
6. Hypothyroxinemia and neurodevelopment 
Animal models for iodine deficiency during pregnancy on development of the CNS have 
been developed for monkeys, sheep and rats.2 These studies have shown changes in 
cerebellum with reductions in weight and cell number, and delayed maturation. The 
influence of maternal hypothyroxinemia on neocortical development has been recently 
studied in rats and mice.60  
6.1 Altered migration during corticogenesis 
The cerebral cortex is composed of neuronal layers with specific functions.39 To form this 
cytoarchitecture, neurons undergo a Tangential migration from the basal epithelium into 
the upper layers of the cortex44. Neuronal migration is highest between the 11th and the 
14th week of gestation, coinciding with the T4 peak in maternal blood serum during 
gestation.32 
During this migration, neurons use glial cells like the steps of a stairway to climb into the 
upper layers39,47. This interaction between glial cells and neurons is enabled by thyroid 
hormones.50,60 
Studies on radial migration during corticogenesis have revealed that in cerebral cortex of 
hypothyroid rats, the radial positioning of migrating neurons is altered48,49, resulting in 
abnormally located Heterotopic neurons in the subcortical white matter (Figure 3)2.  
www.intechopen.com
 
Understanding Prenatal Iodine Deficiency 145 
 
 
 
 
 
Fig. 3. (A—C) Low-magnification photomicrographs of coronal sections of the parietal 
cortex and hippocampus showing BrdU-immunoreactive cells after E17--20 injections in 
control, LMH þ T4, and LMH pups at P40. (D—F) Details (boxes in A, B, and C) showing 
that both in layers I—VI and white matter (wm) the neocortex and the alveus (al) and 
stratum oriens (or) of the hippocampus, the radial distribution of BrdU-immunoreactive 
cells is more widespread in LMH pups than in control and LMH þ T4 pups. Note the 
increased number of heterotopic BrdU-immunoreactive cells in wm, al, and or in LMH pups 
compared with that of control and LMH þ T4 pups. The borders between layers are 
indicated by horizontal lines. LMH= Late maternal hypothyroidism. (Berbel P et al. Cerebral 
Cortex 2010)60 
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6.2 Abnormal cortical cytoarchitecture and connectivity 
Any situation compromising maternal thyroid hormone transfer to the fetus will disturb the 
neuronal migration process. As a result, neurons will not reach their final destination in the 
upper layers and their abnormal positioning will cause alterations in the laminar 
architecture of the cerebral cortex.44 
In biopsies performed in experimental animals maternal thyroid hormone deficiency was 
found to cause permanent and irreversible lesions in the cerebral cortex cytoarchitecture. As 
in gestational hypothyroidism, hypothyroxinemia accuse neocortical layering blurred.  
 
 
 
 
 
 
 
Fig. 4. Left. Photomicrographs of S1 coronal sections from normal and hypothyroid rats, 
showing the distribution of BrdU-labelled cells at P40, following injections at E15 and E17. 
Cells are more widely distributed in hypothyroid rats. Note the increased number of 
labeled cells, with respect to normal, in the white matter (wm) of hypothyroid rats. 
Centre. Photomicrographs of cresyl violet-stained coronal sections showing the PMBSF 
cytoarchitecture and layer borders in normal and hypothyroid rats. In normal rats, 
borders between layers are clear cut, while in hypothyroid rats (dashed lines) they are 
blurred. Note that in layer IV of hypothyroid rats, instead of normal barrels, disperse 
patches of high cell density can be seen. Arrowheads point to two septae adjacent to the 
barrel indicated by the arrow. Right. Plots of retrograde-labeled callosal neurons are 
shown in normal and hypothyroid rats. In normal rats, an important proportion of labeled 
neurones are in supragranular layers II and III. On the contrary, in hypothyroid rats, 
almost all labeled neurones are between layers IV and VI (Berbel P. et al.  
Neuroscience 2001)62.  
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Fig. 5. Thyroid hormones play an important role in the neuronal migration process. 
Specifically, rats born to females with moderately low thyroid hormone levels have a 
disorganized cortical plate and many neurons do not migrate to their normal position. 
Furthermore, this action of thyroid hormones occurs during early fetal life. The figure shows 
the radial (blue arrow)  and tangential (red arrows) migratory pathways. Both are afected by 
maternal hypothyroxinemia resulting in abnormal cortical lamination. (Adapted from Berbel 
P. Mente y Cerebro 2003)63 
7. Physiopathology of fetal cerebral damage 
Within this broad framework, three different situations can be found, with different results: 
When maternal hormone transfer is deficient –as in cases of maternal hypothyroidism or 
hypothyroxinemia–, the hormone concentrations transferred to the embryo and the fetus are 
inadequate during early pregnancy. Later, at the onset of fetal thyroid function, there is 
increased secretion of T4 and T3 by the fetal thyroid gland, though it fails to meet 
successfully the early disruption of maternal hormone supply. Thus, T4 and T3 
concentrations in fetal tissues are fairly normal when the fetus reaches term, but its 
intrauterine development will have suffered alterations.38,64 
However, as the secretion of thyroid hormones increases, the fetal thyroid cannot store 
them. Therefore, neonates to mothers with thyroid malfunction have higher difficulty to 
meet the hormonal needs at birth than neonates to mother with normal thyroid function. 
This situation can lead to permanent neurological abnormalities38,40. 
When the maternal thyroid function is normal, but the fetal function is not –as it is the case in 
congenital hypothyroidism–, maternal T4 and T3 supply can partly mitigate fetal 
hypothyroidism. Although maternal T4 supply cannot replace completely the fetal thyroid 
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function, it is crucial for brain development, where it does maintain normal T3 concentrations. 
However, such concentrations are not maintained in other tissues at normal levels.65  
However, although maternal T3 levels are normal, this does not mitigate T3 deficiency in 
the fetus. The reason is that the fetal brain is totally dependent on the conversion of T4 into 
T3 by local action of 5'D-II, as T3 cannot be taken directly from plasma.38,66  
Thus, these findings prove that maintaining adequate T4 levels in the mother is crucial, as it 
protects the brain of fetuses with congenital hypothyroidism until birth. Conversely, 
although the mother has normal T3 concentrations maintaining maternal euthyroid status, 
this hormone does not protect the fetal brain in mothers with hypothyroxinemia38,40 . 
When both the maternal and the fetal thyroid function are abnormal –as in the case of 
chronic iodine deficiency– mothers have very low levels of T4, though T3 concentrations are 
normal. In this situation, embryos and fetuses have deficient T4 levels during gestation and 
become increasingly deficient in T3.64,67 
 
Fig. 6. In this table, the three clinical situations leading to altered maternal and/or fetal 
thyroid function are shown. It shows how the relative contributions of an altered maternal 
and/or fetal thyroid function can lead eventually to alterations in fetal thyroxine levels 
during intrauterine development. (From Glinoer D, Delange F. The potential repercussions of 
maternal, fetal and neonatal hypothyroxinemia on the progeny. Thyroid 2000, 10 (10): 871-887)64. 
When the fetal thyroid gland should start working, it cannot compensate for the disrupted 
maternal supply, since it does not have enough iodine for the synthesis and secretion of T4. 
At the same time, the fetal brain has not preferential protection from maternal T4, as this 
hormone cannot be biosynthesized due to the deficiency of iodine. As a result, fetal tissues –
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including the fetal brain– are very deficient in T4 and T3 during very important stages of 
cerebral neurogenesis and maturation.41,68 . 
These data suggest that the pathogenic mechanisms that lead to cretinism and severe 
hypothyroidism are multifactorial, and the effects of severe iodine deficiency can be 
amplified by the deleterious effects of thiocyanate overload, selenium deficiency, and 
glandular destruction and fibrosis occurring gradually during childhood69. By contrast, 
when iodine supplementation is given to women in regions with endemic iodine deficiency, 
cretinism can be eradicated, and neonatal hypothyroidism prevented70. 
8. Clinical effects of prenatal iodine deficiency 
Now that we know the "virtually universal" participation of thyroid hormones in the 
development and proliferation of fetal neural tissue, the complex clinical manifestations of 
thyroid hormone deficit in early pregnancy can be easily anticipated. 
Therefore, maternal and fetal hypothyroxinemia caused by iodine deficiency determines 
permanent lesions in the upper cortical areas, hippocampus and cerebellum48,64, which 
causes neurological abnormalities with relatively well-defined characteristics: 
- Brain stem or medullar elements are not affected, so there is no direct motor 
dysfunction, but abnormal motor coordination function39. 
- The lesions affect the integration areas of the cerebral cortex –including “silent” areas of 
the association areas of the cortex– showing poorly defined anatomical alterations. 
- They do not have perinatal clinical expression, although they express later during early 
years of life until school age.71,72 
- Therefore, these lesions cannot be detected by modern prenatal diagnosis techniques.30 
A number of research studies conducted in regions with moderate iodine deficiency have 
shown the presence of irreversible alterations in the intellectual and neuro-psycho-motor 
development of infants and adults that were clinically euthyroid and that did not exhibit 
other signs or symptoms of endemic cretinism, which is the most serious form of brain 
damage caused by iodine deficiency. 
In follow-up studies on infants of mothers with hypothyroxinemia identified in the first 
trimester of pregnancy, low scores were obtained on scales measuring psychomotor 
development (psychometric tests used to find evidence of these abnormalities are varied 
and include adapted intelligence tests, regardless of the subjects’ culture). Such results were 
especially significant in those tests that assess visual-motor coordination, object 
manipulation, understanding the relationship between objects, imitation and early language 
development38,73. The results showed low visual-motor performance, motor skills, 
perceptual and neuromotor skills, and low development and intelligence quotients (IQ)71,76. 
Bleichrodt and Born74 conducted a meta-analysis of 19 studies on neuromotor and cognitive 
functions in conditions of moderate to severe iodine deficiency, and concluded that iodine 
deficiency leads to a loss of 13.5 IQ points, as compared with the global population. Apart 
from goiter, brain damage and loss of intellectual potential caused by iodine deficiency are 
an obstacle to the socioeconomic development of people, and must be considered as a major 
public health problem. 
More recently, iodine deficiency –maternal hypothyroxinemia– has been identified as a 
causal factor of attention-deficit hyperactivity disorder75.  
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9. Fetal and neonatal effects of iodine deficiency
27
 
 
Reference Inclusion criteria Conclusions Comments 
 
Pharoah POD, Buttfield  
IH, Hetzel BS. 
 
Neurological damage to 
the fetus resulting from 
severe iodine deficiency 
during pregnancy 
 
Lancet 1971, 1: 308 
 
Type of participants: Total 
population from 27 
villages in Papua Nueva 
Guinea. 
 
Type of intervention: 
Administration of 
intramuscular iodized 
oil. 
 
Type of results: 
Changing incidence of 
endemic cretinism 
Controlled clinical trial in 
a city of 8,000 
inhabitants. 
 
Intramuscular iodized oil 
is effective for the 
prevention of endemic 
cretinism. To be effective, 
it must be  
administered before 
conception. 
 
Maternal severe iodine 
deficit causes 
neurological damage 
during fetal 
development. 
 
Pioneer intervention 
study on populations 
with severe iodine 
deficit. 
 
The cohort monitored is 
very small, as compared 
with the initial group. 
 
The results obtained are 
expressed in terms of 
infant mortality and 
endemic cretinism 
incidence. 
 
Thilly C, Delange F y 
cols. 
 
Fetal Hypothyroidism 
and maternal thyroid 
status in severe endemic 
goiter 
 
J Clin Endocrinol Metab 
1978; 47: 354 
Type of participants:
A total of 109 pregnant 
women and 128 newborn 
babies from Ubangi, 
Zaire. 
 
Type of intervention: 
Administration of 
intramuscular iodized oil 
to a group of pregnant 
women. 
 
Type of results: 
Changing TSH, T4 and 
T3 concentrations in 
mothers and newborn 
babies.
Maternal thyroid 
function in regions with 
severe endemic goiter is a 
good indicator of the 
thyroid function in a 
neonate. 
 
The factors responsible 
for this hypothetical 
relationship seem to be 
environmental factors 
acting simultaneously in 
the mother and the fetus.
 
Pregnant women were 
grouped “randomly” 
into two groups. 
 
The results obtained are 
shown in thyroid 
function values of the 
mother and the neonate 
at birth. 
 
 
Bleichrodt N, Born MP. 
 
A metaanalysis of 
research on iodine and 
its relationship to 
cognitive development. 
 
Nutr Rev 1996; 54 (4 Pt 
2): S72- S78 
 
Type of participants:
Previous Articles 
 
Type of intervention: 
Metaanalysis of 19 
studies on neuro-motor 
and cognitive functions 
under conditions of 
moderate to severe 
iodine deficiency. 
 
Type of results: 
Depending on the study 
reviewed.
 
 
Iodine deficiency causes 
a decrease of 13.5 IQ 
points as compared with 
the global population. 
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Reference Inclusion criteria Conclusions Comments 
 
 
Haddow JE, Glenn MD y 
cols 
 
Maternal thyroid 
deficiency during 
pregnancy and 
subsequent 
neuropsychological 
development of the child
 
N Engl J Med 1999; 341: 
549.5556 
Type of participants:
62 pregnant women with 
TSH above the 98th 
percentile, and 124 
pregnant women with 
normal TSH levels. 
 
Type of intervention: 
Infants aged 7-9 
underwent 15 tests. 
 
Type of results: 
Scores obtained in 
different 
neuropsychological 
performance tests.
 
Infants of women with 
high TSH concentrations 
scored seven points 
lower than the infants of 
124 control women 
(p=0,005) in the 15 tests 
employed, and 19 
percent scored 85 or even 
lower. 
 
Undiagnosed 
hypothyroidism in 
pregnant women can 
damage the fetus.
 
 
Retrospective study on a 
bank of pregnant women 
serum collected for a 
period of three years. 
 
The results are expressed 
in terms of the scores 
obtained in intelligence, 
attention, language, 
reading skills, school 
performance and 
vasomotor development 
tests. 
Pop VJ, Kuijpens JL y 
cols. 
 
Low maternal free 
thyroxine concentrations 
during early pregnancy 
are associated with 
impaired psychomotor 
development in infancy 
 
Clin Endocr 1999; 50: 
149- 155 
 
Type of participants:
220 pregnant women and 
220 infants at 10 months.
 
Type of intervention: Study 
of maternal thyroid 
function and evaluation 
of the neurological 
development of infants at 
10 months of life. 
 
Type of results: 
Scores obtained by 
children on the Bayley 
Scale of Psycho-motor 
development. 
Low free T4 plasma 
concentrations during 
early pregnancy may be a 
relevant risk factor of 
mental retardation in the 
progeny. 
 
Free T4 concentrations 
are defined as an 
independent parameter 
for the neurological 
development of the 
progeny. 
This is the first study to 
prove that low free TSH 
levels in apparently 
healthy women during 
early pregnancy increase 
significantly the risk of 
fetal neurological 
damage. 
 
Maternal TSH, fT and 
TPO antibodies are 
analyzed at the 12th and 
32th week of gestation. 
 
Consequences at the 12th 
week and the rest of 
weeks of pregnancy. 
 
 
Morreale de Escobar G, 
Obregón MJ y Escobar 
del Rey F. 
 
Is neuropsychological 
development related to 
maternal 
hypothyroidism or to 
maternal 
hypothyroxinemia? 
 
J Clin Endocrinol Metab 
2000; 85: 3975- 3987 
 
 
 
Type of participants: 
Previous articles 
 
Type of intervention: 
Systematic analysis of 
articles published on the 
effects of maternal 
hypothyroxinemia on the 
fetal neurological 
development 
 
Type of results: 
Relying on the study 
reviewed. 
Maternal 
hypothyroxinemia in the 
first trimester increases 
the risk of fetal 
neuropsychological 
damage. 
 
Maternal T4 is the sole 
source of thyroid 
hormone for the fetal 
brain during the first 
trimester. 
 
Normal T3 
concentrations in the 
mother do not prevent 
from potential damaged 
caused by a low T4 
supply 
Through analysis of the 
main findings made in 
regions with severe 
iodine deficiency, in 
regions without iodine 
deficiency and in studies 
with experimental 
animals. 
 
Development of a 
unifying theory on the 
severity and frequency of 
neurological  
damage in the progeny 
of mothers with 
hypothyroxinemia, 
 in contrast with mothers 
with hypothyroidism. 
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10. Studies with potassium iodide supplementation 
Finally, supplementation with potassium iodide (KI) from the early stages of pregnancy in 
pregnant women has proven to be a safe and effective method for preventing cognitive 
impairment associated with nutritional iodine deficiency. 
 
Inclusion criteria Subjects Methods Conclusion Comments Reference 
Pregnant women 
from a moderate 
iodine deficiency 
area. 
Pregnant women 
treated with 
iodized salt 
compared with 
pregnant women 
as control group.
 
Randomized 
Clinical Trial:
35 pregnant 
women of 
which 17 were 
administered 
120-180 µg of 
iodine in form 
of iodized salt. 
Another 18 
women served 
as the control 
group. 
 
Determination 
of TSH, 
Urinary iodine 
excretion (UIE) 
and thyroid 
volume. 
Iodine Urinary 
Excretion in the 
third trimester 
was 
significantly 
higher in the 
group studied 
(100± 39 vs 
50±37 of 
iodine). 
(p<0,0001) 
The thyroid 
volume 
increased 
significantly in 
the control 
group, mainly 
due to relative 
iodine 
deficiency. 
 
Very limited 
sample size. 
The results 
obtained are 
statistically 
significative, 
although the 
sample size was 
very small. 
The authors 
suggest the use of 
iodine 
prophylaxis to 
prevent the 
increase in 
thyroid volume 
and avoid the 
risk of maternal 
and fetal 
hypothyroidism.
Romano R, et 
al,  Am J Obstet 
Gyneol 1991. 
Healthy pregnant 
women, recruited 
at early gestation. 
 
Exclusion criteria: 
thyroid disease or 
medication that 
could affect 
thyroid function 
Pregnant women 
treated with 
potassium iodide 
(KI) solution  
compared with 
pregnant women 
as control group.
 
Randomized 
Clinical Trial:
28 pregnant 
women who 
received 200 
µg/day of 
iodine from 17-
18 weeks of 
gestation until 
12 months after 
delivery. 
A total of 26 
women served 
as the control 
group. 
 
A relatively 
low iodine 
intake during 
pregnancy 
leads to thyroid 
stress, with 
increased 
release of TG 
and of thyroid 
volume, with 
little clinical 
effects, 
according to 
the authors. 
 
Iodine does not 
cause 
significant 
changes in T4, 
T3 or free T4 in 
serum. 
Very small 
sample. 
The conclusions 
can not be 
considered as 
definitive. 
The same group 
presented seven 
years later a 
study with 
opposite results.
Pedersen KM, 
Laurberg P and 
cols;  J Clin 
Endocrinol 
Metab 1993 
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Inclusion criteria Subjects Methods Conclusion Comments Reference 
Euthyroid 
pregnant women, 
selected at the end 
of the first 
trimester with 
biochemical 
criteria of 
excessive thyroid 
stimulation 
(thyroglobuline ↑, 
with a low normal  
free T4 index 
and/or increased 
T3/T4 ratio. 
Study with a 
control group 
and two groups 
that received 
100µg/day of 
iodine and the 
other 100 µg/day 
of iodine+ 100 
µg/day of T4. 
N=60 pregnant 
women in each 
group. 
 
Randomized 
clinical trial, 
double-blind: 
In both groups 
of women who 
received active 
treatment, 
alterations in 
thyroid 
function 
associated with 
pregnancy 
improved 
significantly. 
Maternal and 
neonatal 
parameters of 
thyroid 
function, UIE 
and thyroid 
volume were 
assessed by 
ultrasound 
The 
administration 
of T4 failed to 
mask the 
beneficial 
effects of iodine 
supplementatio
n in pregnant 
women, 
especially in 
the prevention 
of goiter. 
 
As a starting 
point, the 
researchers 
selected a 
population at risk 
relying on 
biochemical 
parameters 
indicating 
thyroid 
overstimulation.
The results can 
not be 
extrapolated to 
normal 
populations of 
pregnant women.
Glinoer D et 
al, 
J Clin 
Endocrinol 
Metab 1995 
Healthy pregnant 
women at 10-12 
weeks of 
gestation. 
Clinical trial , 
pregnant women 
who received IK 
were compared 
with a control 
group. 
Non 
randomized 
clinical trial 
with 108 
women, of 
whom 38 
received 300 µg 
of IK/day (230 
µg of iodine) 
and 70 served 
as the control 
group. 
Thyroid 
volumen, 
thyroid 
function, UIE 
and TPO 
antibody levels 
were measured 
in the week 10-
12 and after 
delivery. 
 
After receiving 
iodine 
fortification, 
IUE increased 
significantly in 
mothers and 
neonate 
The thyroid 
volumen in 
neonates to 
mothers that 
received 
fortification 
was lower than 
that of the 
control group
Iodine 
supplementation 
during 
pregnancy in 
regions with 
moderate iodine 
deficiency causes 
a lower thyroid 
volume in 
neonate. 
This 
supplementation 
does not increase 
TPO antibody 
frequency 
Liesenkötter 
KP et al. 
Eur J 
Endocrinol 
1996 
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Inclusion criteria Subjects Methods Conclusion Comments Reference 
Pregnant women, 
entering the study 
at any stage of 
pregnancy. 
Clinical trial with 
pregnant women 
treated with IK 
and compared 
with a control 
group. 
 
 
Non 
randomized 
and 
comparative 
study in 
pregnant 
women, of 
whom 93 
received  
150 µg/day 
of iodine and 
419 served 
 as control 
group. 
Determination 
of UIE  
and T4L  
during 
pregnancy, 
anti-TPO, anti-
TG, maternal 
and neonatal 
thyroid  
volume 
Iodine 
supplementatio
n  enhances 
significantly 
IUE and T4L 
levels during 
the whole 
gestation. 
Lower 
maternal and 
neonatal 
thyroid volume 
was found in 
the group that 
received 
supplementation.
 
The control 
group consisted 
of a significant 
sample of 
pregnant women.
In both groups 
UIE increases 
progressively 
during 
pregnancy, but 
the control group 
had normal 
urinary iodine 
excretion <100 
mg / L during 
pregnancy. 
 
De Santiago J, 
et al 
J Endocrinol 
Invest 1999 
Mother/newborn 
pairs. 
All newborns 
were healthy and 
delivered at term 
and were 
breastfed. 
Babies from 
mother treated 
with IK 
compared with 
babies from a 
control group 
Randomized 
clinical trial in 
89 mothers and 
their babies:  57 
served as the 
control group, 
32 received 175 
µg IK/day (134 
µg of iodine) 
during 
pregnancy. 
Identification 
of thyroid 
volumen UIE, 
nutritional 
questionnaire 
 
UIE of neonates 
to 
supplemented 
mothers 
increased  
by 62 percent, 
while the 
thyroideal 
volume of 
these children 
decreased  
by 18 percent, 
as compared 
with the 
control group.
Neonatal TSH 
was 
maintained 
within normal 
ranges. 
 
It DOES NOT 
include maternal 
thyroid function 
values. 
In this study, the 
fact that the 
mother was a 
smoker was 
taken into 
account. 
Babies born to 
smoking mothers 
had 20 percent 
higher thyroid 
volume than 
those born to non 
smokers. 
Klett M et al 
Acta 
Paediátrica 
Suppl 1999 
www.intechopen.com
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Inclusion criteria Subjects Methods Conclusion Comments Reference 
Healthy pregnant 
women with no 
previous history 
of thyroid disease 
were recruited 
when admitted for 
delivery. 
Pregnant women 
that have taken 
IK were 
compared with a 
control group. 
Babies from 
mother treated 
with IK 
compared with 
babies from a 
control group 
Observational 
study  144 
women and 
their progeny 
participated in 
the study, of 
which 49 
received 150 µg 
iodine/day 
during 
pregnancy and 
95 served as 
control 
subjects. 
Identification of 
maternal 
thyroid 
function (TSH, 
T4L, T3L, TG) 
and neonatal 
function in 
cord blood 
(TSH, T4L, T3L, 
thyroglobulin) 
Researchers 
found that TSH 
has an opposite 
behavior in the 
mother 
(decreases) to 
that of the 
neonate 
(increases) in 
the group 
supplemented 
with iodine. 
T4L is higher in 
the mothers 
and infants of 
the 
supplemented 
group. 
The authors 
attribute the rise 
in TSH to a 
transient impasse 
of neonatal 
iodine-induced 
thyroid. 
 
Nøhr S, 
Laurberg P 
TPO-Ab-positive 
women in early 
pregnancy 
Three groups of 
study stratified 
by anti-TPO titers 
into 3 groups: 22 
women received 
150 mg iodine / 
day from 
conception up to 
9 months 
postpartum 
(+/+), only 24 
received iodine 
during 
pregnancy and 26 
(+/-) did not 
receive iodine (-
/-). 
Placebo-
controlled, 
randomized, , 
double blind 
trial. 
 
Study of 
thyroid 
function at 35 
weeks of 
gestation and 9 
months after 
delivery. 
They found 
that the 
incidence, 
severity and 
type of thyroid 
dysfunction 
postpartum rely 
predominantly 
on anti-TPO 
levels (positive 
correlation). 
Supplementati
on with iodine 
during 
pregnancy and 
postpartum 
does not induce 
or worsen 
postpartum 
thyroid 
dysfunction. 
 
The authors 
concluded that 
iodine 
supplementation 
during 
pregnancy and 
postpartum is 
safe, even in 
women with 
positive anti-
TPO. 
Screening for 
anti-TPO in the 
first trimester can 
predict women at 
risk of 
developing 
postpartum 
thyroid 
dysfunction. 
Nøhr S, et al 
J Clin 
Endocrinol 
Metab 2000 
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Inclusion criteria Subjects Methods Conclusion Comments Reference 
Pregnant women 
enrolled from the 
10th to the 16th 
week of gestation.
32 pregnant 
women 
supplemented 
with 50 µg/day 
of iodine (group 
A) and 35 
received 200 
µg/day (group B) 
from conception 
to 6 months after 
delivery. 
 
Randomized 
clinical study
Determination 
of thyroid 
volume, 
thyroid 
function in all 
three trimesters 
of pregnancy. 
 
The dose of 50 
µg/day is an 
inexpensive 
and safe 
method to 
prevent goiter.
The dose of 200 
µg/day seems 
to be more 
effective, has 
not side effects 
and does not 
increase the 
frequency of 
autoimmune 
postpartum 
thyroiditis. 
There were not 
any control group, 
since the 
Committee of 
Ethics and Clinical 
Research did not 
give authorization.
Five cases of 
postpartum 
thyroiditis (2 in 
group A and 3 in 
group B) were 
detected. All these 
women had low 
circulating 
autoantibodies 
before starting the 
test.
Antonangeli L 
et al 
Eur J 
Endocrinol 
2002 
Children whose 
mothers were  
supplemented 
during pregnancy.
 
The comparison 
group were 
children recruited 
at 2 years of age. 
148 infants of 
mothers who 
received iodine 
supplementation 
during 
pregnancy were 
compared with 
169 infants who 
received iodine 
aged from 2 
years, for a 
period of 1 year.
 
There were no 
untreated group.
Longitudinal 
study. 
Psychometric 
tests used: 
Raven 
Progressive 
Matrices, 
Developmental 
test of Visual 
Motor 
Integration 
(VMI) and 
Denver 
Developmental 
Screening Test 
(DDST).
Iodine before 
the 3rd trimester 
predicted 
higher 
psychomotor 
test scores for 
children 
relative to 
those provided 
iodine later in 
pregnancy or at 
2 years of age.
Iodine 
supplementation 
was carried out 
by adding it to 
the irrigation 
water. 
O’Donnell K, 
et al 
Develop Med 
& Child 
Neurol 2002 
Pregnant women 
at the first 
trimester of 
gestation for the 
study group. 
 
Pregnant women 
at the third 
trimester of 
gestation for 
control group. 
The study 
included 133 
women who 
received 300 µg 
of potassium 
iodine and 61 
women who had 
received no 
iodine 
supplements. 
Non 
randomized, 
clinical trial. 
 
Main outcome 
measures: 
Bayley Scales of 
Infant 
Development.
 
Maternal and 
infant thyroid 
function: TSH, 
free T3, free T4 
and urine iodine
Infants whose 
mothers had 
received an 
iodine 
supplement had 
more favorable 
psychometric 
assessment and 
higher scores on 
the 
Psychomotor 
Development 
Index 
(p =0,02) and the 
Behavior Scale.
Given the 
possible presence 
of confounding 
variables no 
controlled for in 
this study, these 
findings should 
be considered as 
preliminary. 
Velasco I et al 
J Clin 
Endocrinol 
Metab 
2009; 
www.intechopen.com
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Inclusion criteria Subjects Methods Conclusion Comments Reference 
Group 1 included 
infants of women 
with FT4 above 
the 20th percentile 
at 4-6 gestational 
weeks and at full-
term. 
Group 2 included 
neonates to 
women with mild 
hypothyroxinemia 
diagnosed during 
the first 12-14 
gestational weeks 
and with FT4 
above the 20th 
percentile at full-
term. 
Group 3 included 
infants born to 
women with mild 
hypothyroxinemia 
without iodine 
supplementation 
during pregnancy.
Three groups of 
infants were 
compared. 
Women of all 
groups were 
iodine 
supplemented 
from the day of 
enrolment until 
the end of 
lactation. 
 
Clinical trial 
 
Psychometric 
Test: Brunet-
Lézine Scale at 
18 months of 
age. 
 
Delayed 
Neuro-
behavioral 
performance 
was observed 
in 36.8 percent 
and 25.0 
percent of 
infants in 
groups 3 and 2, 
respectively, as 
compared with 
infants in 
group 1. 
 
 
 
 
A delay of 6-10 
weeks in iodine 
Fortification of 
Hypothyroxine
-mic mothers at 
the beginning 
of gestation 
increases the 
risk of 
neurodevelop
mental delay in 
the progeny. 
Women of all 
groups were 
iodine 
supplemented 
(200 µg KI per 
day) from the 
day of enrollment 
until the end of 
lactation. 
 
 
No women were 
found to be 
Hypothyroxine-
mic at full-term 
after 
supplementation.
Berbel P, et al. 
Thyroid 2009 
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